Transmyocardial laser revascularization: current status.
Transmyocardial laser revascularization (TMLR) has been widely evaluated for treatment of the ischemic myocardium either in conjunction with coronary artery bypass grafting or as sole therapy. Clinically, it has shown significant improvement for angina symptoms, but the mechanism by which this modality works is unknown at this time. The original premise on which transmyocardial revascularization was established depended on its ability to essentially generate channels that would directly carry blood from the ventricle into the ischemic myocardium. This theory, however, has not been substantiated, so other mechanisms have been postulated. This article gives a historical perspective on the advent of transmyocardial revascularization and the many animal and human studies that have paved the way for its clinical use. Current controversies are examined, along with the new advances in laser technology and where the future of TMLR is headed.
Puc
M M
MM
Department of Surgery, Cooper Hospital/University Medical Center, Camden, New Jersey 08103, USA.
Levin
S
S
Tran
H S
HS
Marra
S
S
Hewitt
C W
CW
DelRossi
A J
AJ
D000818:Animals; D001026:Coronary Artery Bypass; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D017202:Myocardial Ischemia / Q000601:surgery*; D009204:Myocardial Revascularization / Q000379:methods*